Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ERSP recommends Perricone modify ads

This article was originally published in The Tan Sheet

Executive Summary

Perricone MD will clarify Cold Plasma Skin Cream claims that are based on consumer perceptions rather than "clinical proof," as recommended by the Electronic Retailing Self-Regulation Program. For example, a four-week, blinded consumer perception study in which 202 subjects evaluated the product after the first and fourth weeks, did not support claims that "skin will look lifted and firmer in minutes." Perricone based the claim on 85 percent of study participants saying Cold Plasma imparted "instant results." But ERSP said the product's capacity to firm and lift were not addressed in the survey question. The watchdog also said the firm could not assume that consumers understood the word "instant" to mean "within minutes." While Perricone disagrees with ERSP, it says it will take the panel's guidance into consideration

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103914

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel